Processing joint Food and Drug Administration and European Medicines Agency voluntary genomic data submissions within the framework of the confidentiality arrangement

Current version

PDF iconAdopted guideline

Published19/05/2006
Effective from19/05/2006
KeywordsJoint FDA-EMA voluntary genomic data submission (VGDS)
DescriptionThis document explains how the U.S. Food and Drug Administration and the European Medicines Agency will process requests for joint FDA-EMA voluntary genomic data submission (VGDS) briefing meetings.

How useful was this page?

Add your rating